Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Anixa Biosciences ( (ANIX) ) has issued an update.
On March 20, 2025, Anixa Biosciences, Inc. held its annual meeting of stockholders, where 20,691,253 shares were represented. During the meeting, stockholders re-elected four directors, approved the executive compensation on a non-binding basis, ratified the appointment of Haskell & White LLP as the independent accounting firm for the fiscal year ending October 31, 2025, and decided on a one-year frequency for future advisory votes on executive compensation.
More about Anixa Biosciences
YTD Price Performance: 32.49%
Average Trading Volume: 113,324
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $98.2M
For a thorough assessment of ANIX stock, go to TipRanks’ Stock Analysis page.